Current hemoglobin levels are more predictive of disease progression than hemoglobin measured at baseline in patients receiving antiretroviral treatment for HIV type 1 infection

The role of hemoglobin levels as an independent prognostic marker of progression to AIDS and/or death in HIV-infected patients starting combination antiretroviral therapy (cART) was investigated. A total of 2,579 patients from the EuroSIDA cohort with hemoglobin, CD4 cell count, and HIV RNA viral lo...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	AIDS research and human retroviruses 2007-10, Vol.23 (10), p.1183-1188
Hauptverfasser:	Kowalska, Justyna D, Mocroft, Amanda, Blaxhult, Anders, Colebunders, Robert, van Lunzen, Jan, Podlekareva, Daria, Hansen, Ann-Brit Eg, Machala, Ladislav, Yust, Israel, Benfield, Thomas
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult AIDS/HIV Anemia Anti-HIV Agents - therapeutic use Antiviral agents CD4 Lymphocyte Count Cohort Studies Complications and side effects Development and progression Disease Progression Dosage and administration Drug therapy Female Health aspects Hemoglobin Hemoglobins - analysis HIV infection HIV Infections - blood HIV Infections - drug therapy HIV Infections - physiopathology HIV Infections - virology HIV-1 - physiology Humans Male Measurement Medicin och hälsovetenskap Middle Aged Patient outcomes Prognosis Viral Load
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The role of hemoglobin levels as an independent prognostic marker of progression to AIDS and/or death in HIV-infected patients starting combination antiretroviral therapy (cART) was investigated. A total of 2,579 patients from the EuroSIDA cohort with hemoglobin, CD4 cell count, and HIV RNA viral load measured 6 months prior to starting cART was included in the analyses. Anemia was defined as mild (
ISSN:	0889-2229 1931-8405
DOI:	10.1089/aid.2006.0292